35 y. ago State Visit to the People's Republic of China by HM King Taufa‘ahau Tupou IV and Queen Halaevalu Mata‘aho

State Visit to the People's Republic of China by HM King Taufa‘ahau Tupou IV and Queen Halaevalu Mata‘aho  Matangi Tonga

Politics

39 m. ago Why are Hongkongers waiting so long under Canada’s pathway to residency?

Hongkonger Cecilia moved to Canada in 2023, believing it to be the cheapest and easiest way for her to get permanent residency overseas. The 32-year-old, who asked to be referred to by her first name due to privacy concerns, was part of an emigration wave that saw tens of thousands of Hongkongers leave the city in recent years. She expected to wait only six months after filing her permanent residency application in April last year, based on the experience of a friend who moved in 2021. But more...

Politics

39 m. ago Chinese man sues fiancée for US$7,000 in gifts, dating expenses, claims she eats too much

A “petty” Chinese man has faced online scorn after he sued his fiancée to get back all the money he had spent on her because she “ate too much”. A court hearing involving the ex-couple went viral on social media after it was reported on December 9. According to the Chinese media outlet Zonglan News, the man, surnamed He, sued his girlfriend, surnamed Wang, to secure the return of a 20,000-yuan (US$2,800) initial bride price payment his family had made to her family. He also demanded that Wang...

Politics

99 m. ago Patent cliffhanger: will China biotech throw Big Pharma a lifeline?

If pharmaceutical drug patents are an hourglass turned over on the day of approval – with the approaching loss of exclusivity known in the industry as the “patent cliff” – then Big Pharma is currently watching the final grains of sand slipping through the neck of the glass. At the bottom of the hourglass awaits an unforgiving world of generic and biosimilar competition. Between 2025 and 2030, the patent cliff is set to be one of the biggest since 2010 by revenue at risk, according to...

Science

99 m. ago Will China biotech be a hard pill to swallow for US Big Pharma?

Will China biotech be a hard pill to swallow for US Big Pharma?  South China Morning Post

Science

2 h. ago Nike CEO Elliot Hill’s Turnaround Plan Hits a Roadblock In China

Nike CEO Elliot Hill’s Turnaround Plan Hits a Roadblock In China  observer.com

Events

3 h. ago Stock Market Today, Dec. 19: Nike Shares Slide After Weak China Sales and Margin Pressure

Stock Market Today, Dec. 19: Nike Shares Slide After Weak China Sales and Margin Pressure  Nasdaq

Economics

3 h. ago China shoppers swap boutiques for bargains, fuelling US$30 billion luxury resale boom

At a shopping centre in Shenzhen’s coastal business district, a store’s entrance feels more like a security checkpoint than a retail gateway. Customers check their bags, don white silk gloves, and pass through a gate. Beyond the checkpoint, which also seems incongruent with the outer facade resembling a typical multi-brand fashion shop, lies a 2,000-square-metre (21,527-sq-ft) showroom. Inside, luxury handbags are not displayed under artful lighting. Instead, they are tightly arranged in...

Economics

3 h. ago Charles Payne: Make no mistake — China is determined to rule

Charles Payne: Make no mistake — China is determined to rule  Fox Business

Politics

4 h. ago Protection of vulnerable workers must be part of China’s AI strategy

Given the breakneck speed of technological and commercial developments across the world, China is perhaps one of only a few sovereign states with a comprehensive strategy on both artificial intelligence (AI) and robotics. The Chinese state philosophy in AI development is anchored in diffusion, as opposed to maximising the cutting-edge performance of select generative or reasoning models. While American and European investors are lured by the prospects of superintelligent and humanoid robots,...

Politics

4 h. ago Opinion | Protection of vulnerable workers must be part of China’s AI strategy

Opinion | Protection of vulnerable workers must be part of China’s AI strategy  South China Morning Post

Politics

4 h. ago US lawmakers want DeepSeek, Xiaomi added to list of China military

US lawmakers want DeepSeek, Xiaomi added to list of China military-linked firms  South China Morning Post

Events

5 h. ago Nike Beats on Earnings But Struggles in China and Faces Tariffs

Nike Beats on Earnings But Struggles in China and Faces Tariffs  MarketBeat

Politics

5 h. ago Economist says trade tensions with China in 2025 could have lasting impacts on U.S. ag exports

Economist says trade tensions with China in 2025 could have lasting impacts on U.S. ag exports  Brownfield Ag News

Events

5 h. ago After a 95% Crash, This China Education Stock Has Drawn a $35 Million Bet From One Institutional Investor

After a 95% Crash, This China Education Stock Has Drawn a $35 Million Bet From One Institutional Investor  The Motley Fool

Economics

6 h. ago Report warns China drug innovation fast gaining ground on US biotech

Report warns China drug innovation fast gaining ground on US biotech  FirstWord Pharma

Events

6 h. ago Golden Goose gets new majority owner as China's HSG buys stake from Permira

Golden Goose gets new majority owner as China's HSG buys stake from Permira  Reuters

Politics

6 h. ago ZHANGYE chats China EDM compilations, electronic production and collaborating with Steve Aoki [Interview]

ZHANGYE chats China EDM compilations, electronic production and collaborating with Steve Aoki [Interview]  EARMILK

Politics

6 h. ago China’s NMPA Accepts New Drug Application for Tinengotinib Tablets for Advanced Cholangiocarcinoma

China’s NMPA Accepts New Drug Application for Tinengotinib Tablets for Advanced Cholangiocarcinoma  OncLive

Events

7 h. ago How China's underdog status in the AI arms race is fueling their approach

How China's underdog status in the AI arms race is fueling their approach  KUOW

Politics